A 25-year-old man presents with recurrent mouth ulcers, genital ulcers, and erythema nodosum on his shins. He also complains of joint pain and eye irritation. What is the most likely diagnosis?
A 40-year-old woman presents with fatigue, muscle aches, and morning stiffness lasting over 1 hour. She has tender points at multiple sites including neck, shoulders, and hips. Blood tests including ESR and CRP are normal. What is the most likely diagnosis?
A 50-year-old woman presents with progressive muscle weakness, particularly affecting her shoulders and hips. She has difficulty rising from chairs and climbing stairs. Her CK is elevated at 2000 U/L. EMG shows myopathic changes. What is the most likely diagnosis?
A 35-year-old man presents with acute onset severe pain and swelling in his right great toe. The joint is red, hot, and extremely tender. His serum uric acid is 450 μmol/L (normal 200-430). What is the most appropriate acute treatment?
A 35-year-old woman presents with recurrent miscarriages (3 in the past 2 years) and a history of deep vein thrombosis. Blood tests show prolonged APTT that doesn't correct with mixing studies. What is the most likely diagnosis?
A 50-year-old woman presents with a 6-month history of dry eyes and dry mouth. She also complains of joint pain in her hands and fatigue. Blood tests show positive anti-Ro and anti-La antibodies. What is the most likely diagnosis?
A 45-year-old man presents with a 2-month history of weight loss, night sweats, and painless lymph node enlargement in his neck. Lymph node biopsy shows Reed-Sternberg cells. What is the most likely diagnosis?
A 44-year-old woman presents with fatigue, joint pain, and a malar rash. Blood tests show ANA 1:640 (homogeneous pattern), anti-dsDNA positive, low C3 and C4. Urinalysis shows proteinuria and hematuria. What is the most likely diagnosis?
A 29-year-old woman presents with fatigue, pallor, and spoon-shaped nails (koilonychia). Blood tests show Hb 7.5 g/dL. MCV 65 fL, ferritin 8 µg/L. What is the most likely cause?
A 65-year-old woman presents with severe bone pain, particularly in her back and ribs. X-rays show multiple lytic lesions throughout the skeleton. Blood tests show elevated calcium and raised ESR. What investigation would be most helpful?
Explanation: ***Behçet's disease*** - The constellation of recurrent **oral ulcers**, **genital ulcers**, and **ocular lesions** (eye irritation) along with **erythema nodosum** and **joint pain** is highly characteristic of Behçet's disease, a systemic vasculitis. - This multisystem inflammatory condition primarily affects small and large vessels and often presents with these mucocutaneous, ocular, and musculoskeletal symptoms. *Herpes simplex infection* - While **herpes simplex** causes recurrent oral and genital ulcers, these are typically **vesicular** before ulceration and are not typically associated with systemic manifestations like **erythema nodosum**, widespread **arthralgia**, or the severe **ocular inflammation** seen in Behçet's. - It is a localized viral infection and does not explain the broad systemic inflammatory presentation described. *Crohn's disease* - **Crohn's disease**, an inflammatory bowel disease, can cause oral aphthous ulcers and perianal lesions, but **genital ulcers** as described here (distinct from perianal) and **erythema nodosum** are not core diagnostic features. - The primary symptoms of Crohn's involve chronic **gastrointestinal inflammation**, which is not the predominant clinical picture in this patient. *Aphthous stomatitis* - **Aphthous stomatitis** explains only the **recurrent mouth ulcers**. - It does not account for the other significant symptoms, including **genital ulcers**, **erythema nodosum**, **joint pain**, and **eye irritation**, which indicate a systemic disorder. *Systemic lupus erythematosus* - **Systemic lupus erythematosus (SLE)** can cause oral ulcers and joint pain (**arthralgia/arthritis**), but **genital ulcers** and **erythema nodosum** are not typical primary diagnostic criteria or common presentations of SLE. - While SLE is a systemic autoimmune disease, the specific combination of symptoms points more strongly towards Behçet's disease.
Explanation: ***Fibromyalgia***- This diagnosis is strongly suggested by the combination of chronic, widespread pain, fatigue, prolonged **morning stiffness** (>1 hour), and the presence of multiple definitive **tender points**.- Crucially, fibromyalgia is a non-inflammatory centralized pain disorder, evidenced by the **normal ESR and CRP** results, ruling out most inflammatory arthropathies.*Rheumatoid arthritis*- RA typically presents with objective **synovitis** (joint swelling) and limited use of specific joints, particularly small joints of the hands and feet, which is not described here.- Active RA is an inflammatory disease and would typically show **elevated ESR and CRP**, making it an unlikely diagnosis with normal laboratory findings.*Systemic lupus erythematosus*- SLE is a multi-system autoimmune disorder that often involves specific organ manifestations (e.g., rash, hematologic issues, nephritis) and would usually present with abnormal immunologic markers (e.g., positive **ANA** or anti-dsDNA).- Like RA, active SLE often causes **elevated inflammatory markers (ESR and CRP)**, conflicting with the patient's normal blood test results.*Polymyalgia rheumatica*- PMR causes severe aching and stiffness primarily restricted to the **shoulder and hip girdles** (proximal symptoms), not widespread body tenderness.- A hallmark feature of PMR is a **dramatically elevated ESR and CRP**, which is absent in this case.*Hypothyroidism*- While hypothyroidism can cause fatigue and **myalgia**, it would not typically cause the specific pattern of widespread **tender points** required for a fibromyalgia diagnosis.- Diagnosis relies on abnormal **TSH and free T4** levels; pain and stiffness are less prominent features than in inflammatory or primary pain disorders like fibromyalgia.
Explanation: ***Polymyositis***- The patient's presentation with progressive, symmetric **proximal muscle weakness** affecting shoulders and hips, leading to difficulty rising from chairs and climbing stairs, is a classic feature of polymyositis.- A significantly elevated **CK (2000 U/L)** indicates substantial muscle damage, and **myopathic changes** on EMG confirm a primary muscle disorder, all consistent with polymyositis.*Polymyalgia rheumatica*- Polymyalgia rheumatica (PMR) primarily presents with severe muscle **pain and stiffness**, especially in the shoulders and hips, but not objective **muscle weakness**.- In PMR, **CK levels are typically normal**, which contrasts with the markedly elevated CK found in this patient.*Myasthenia gravis*- Myasthenia gravis (MG) causes **fluctuating muscle weakness** and **fatigability** that worsens with activity and improves with rest, often starting with ocular or bulbar symptoms.- **CK levels are normal** in MG, and EMG demonstrates a **decremental response** to repetitive nerve stimulation, indicating a defect at the neuromuscular junction, not muscle inflammation.*Motor neuron disease*- Motor neuron disease (MND) involves signs of both upper and/or lower **motor neuron damage**, such as spasticity, fasciculations, and muscle atrophy, but no sensory deficits.- EMG in MND shows **neurogenic changes** (denervation and reinnervation), and **CK levels are usually normal** or only mildly elevated, not significantly high.*Hypothyroidism*- Hypothyroid myopathy can cause muscle stiffness, cramps, and sometimes **mild-to-moderate proximal weakness**, with **CK levels usually mildly to moderately elevated**.- A CK of 2000 U/L is very high for uncomplicated hypothyroid myopathy, and the primary diagnosis would require abnormal **thyroid function tests**, which are not mentioned.
Explanation: ***Ibuprofen*** - **Non-steroidal anti-inflammatory drugs (NSAIDs)** like ibuprofen are the **first-line treatment** for acute gout flares, rapidly reducing severe pain and inflammation due to **uric acid crystal deposition**. - They act by inhibiting **cyclooxygenase (COX) enzymes**, thereby blocking prostaglandin synthesis, which is crucial for managing the intense inflammatory response characteristic of **podagra**. *Allopurinol* - **Allopurinol** is a **xanthine oxidase inhibitor** primarily used for **long-term prophylaxis** to lower serum uric acid levels, not for acute management of a flare. - Initiating allopurinol during an acute attack is generally **contraindicated** as it can mobilize uric acid stores, potentially prolonging or worsening the attack. *Colchicine* - **Colchicine** is an effective anti-inflammatory agent for acute gout, but it's typically a **second-line** option or preferred if started very early (ideally within 12-24 hours of onset). - Its use is often limited by a narrow therapeutic window and dose-dependent **gastrointestinal side effects** such as diarrhea and nausea. *Prednisolone* - **Prednisolone** (corticosteroids) is highly effective for acute gout but is generally reserved for patients who cannot tolerate NSAIDs or colchicine, or those with severe, polyarticular attacks. - Systemic steroids are considered **second- or third-line options**, particularly when NSAIDs are contraindicated (e.g., severe renal failure, heart failure, active peptic ulcer disease). *Paracetamol* - **Paracetamol (Acetaminophen)** is a simple analgesic and antipyretic that **lacks significant anti-inflammatory properties**. - It is insufficient for controlling the intense **chemical inflammation** and severe pain characteristic of an acute gout flare, making it an inappropriate primary treatment.
Explanation: ***Antiphospholipid syndrome***- The combination of **recurrent miscarriages** and a history of **deep vein thrombosis (DVT)** is a hallmark clinical presentation of Antiphospholipid Syndrome (APS).- The finding of a **prolonged APTT** that fails to correct with a normal plasma mixing study is highly suggestive of **lupus anticoagulant (LA)**, a key diagnostic criterion for APS.*Factor V Leiden mutation*- This condition causes **resistance to activated protein C**, primarily increasing the risk of **venous thrombosis**.- Routine coagulation tests like **aPTT** are typically **normal** in individuals with this mutation.*Protein C deficiency*- This disorder primarily increases the risk of **venous thrombosis** but is less frequently associated with recurrent fetal loss compared to APS.- Coagulation screening tests (**PT** and **aPTT**) are generally **normal** in individuals with this deficiency.*Prothrombin gene mutation*- This mutation (G20210A) results in increased levels of **prothrombin (Factor II)** and primarily causes an increased risk of **venous thrombosis**.- Standard coagulation assays (**PT** and **aPTT**) typically remain **normal** in affected individuals.*Antithrombin deficiency*- This deficiency causes a severe, high-risk state for **venous thrombosis** (DVT/PE).- Although it causes hypercoagulability, it is not strongly associated with the specific combination of thrombosis and **recurrent miscarriages** defining APS, and baseline aPTT is usually normal.
Explanation: ***Sjögren's syndrome*** - The classic triad of **dry eyes (xerophthalmia)**, **dry mouth (xerostomia)**, and **arthralgia** is highly characteristic of Sjögren's syndrome. - The presence of **positive anti-Ro (SSA)** and **anti-La (SSB) antibodies** further confirms the diagnosis, as these are specific markers for Sjögren's. *Systemic lupus erythematosus* - While anti-Ro/La antibodies can be positive in a subset of SLE patients, the primary presentation in SLE typically includes **malar rash**, **photosensitivity**, **serositis**, or **renal involvement**, which are not the dominant features here. - SLE is a multisystem autoimmune disease with a broader spectrum of manifestations beyond isolated sicca symptoms and joint pain. *Rheumatoid arthritis* - Rheumatoid arthritis primarily presents with **inflammatory synovitis** affecting small joints, characterized by morning stiffness and swelling, often symmetric. - While secondary Sjögren's can occur in RA, the primary complaint of prominent dry eyes and dry mouth with positive anti-Ro/La antibodies makes Sjögren's the more direct diagnosis. *Systemic sclerosis* - Systemic sclerosis is characterized by **skin thickening (scleroderma)**, **Raynaud's phenomenon**, and potential **internal organ fibrosis** (e.g., lungs, GI tract). - Although some patients may experience sicca symptoms, the hallmark skin changes and specific autoantibodies (anti-Scl-70, anti-centromere) are typically present, which are not described. *Polymyalgia rheumatica* - Polymyalgia rheumatica is characterized by **bilateral pain and stiffness** in the **shoulders and hip girdle**, often worse in the morning, typically in older adults. - It does not involve prominent sicca symptoms or specific hand joint pain, and anti-Ro/La antibodies are not associated with this condition.
Explanation: ***Hodgkin's lymphoma*** - The presence of **Reed-Sternberg cells** (large, often binucleated cells with prominent nucleoli) in the lymph node biopsy is pathognomonic for Hodgkin's lymphoma (HL). - The constitutional symptoms of **weight loss** and **night sweats**, known as **B symptoms**, are classic presenting features highly suggestive of HL in a patient with painless lymphadenopathy. *Non-Hodgkin's lymphoma* - This group of malignancies is very heterogeneous but is *not* defined by the presence of **Reed-Sternberg cells**, which are unique to HL. - NHL typically arises from B or T lymphocytes, often presents later in life, and frequently involves extranodal sites without this specific cellular hallmark. *Chronic lymphocytic leukemia* - CLL is characterized by the proliferation of small, mature, **CD5+/CD23+ B-cells** and typically involves striking peripheral blood lymphocytosis. - The lymph node architecture in CLL would be effaced by these small lymphocytes, not by large, atypical cells like **Reed-Sternberg cells**. *Infectious mononucleosis* - This is an acute, self-limiting infection, usually caused by **Epstein-Barr virus (EBV)**, and would typically not cause chronic **B symptoms** lasting 2 months. - While *Reed-Sternberg-like cells* can sometimes be observed in reactive conditions, true **Reed-Sternberg cells** along with B symptoms point definitively to malignancy. *Metastatic carcinoma* - The biopsy showing **Reed-Sternberg cells**, which are lymphoid in origin, rules out metastatic carcinoma. - Metastatic carcinoma would show nests of **epithelial cells** (usually positive for **cytokeratin**) without features of a primary hematolymphoid malignancy.
Explanation: ***Systemic lupus erythematosus***- The combination of **malar rash**, fatigue, joint pain, high titer **ANA** (homogeneous pattern), and the presence of **anti-dsDNA antibodies** is highly specific and diagnostic for **Systemic Lupus Erythematosus (SLE)**.- The findings of **low C3 and C4** indicate active disease with **complement consumption**, which, along with **proteinuria and hematuria**, strongly suggests the presence of active **lupus nephritis**.*Drug-induced lupus*- This condition is typically characterized by the presence of **anti-histone antibodies**, rather than high titers of anti-dsDNA antibodies.- Drug-induced lupus is usually milder and rarely involves key major organs like the kidneys, making severe **nephritis** with proteinuria and hematuria unlikely.*Mixed connective tissue disease*- MCTD is defined by very high titers of **anti-U1-RNP antibodies** and an overlap of features, but high **anti-dsDNA** and severe nephritis are less characteristic.- While overlap can occur, the prominent **anti-dsDNA positivity** and severe **lupus nephritis** of this magnitude are far more indicative of pure SLE than MCTD.*Sjögren's syndrome*- The primary presentation of Sjögren's involves **sicca symptoms** (dry eyes and mouth) and is associated with antinuclear antibodies like **anti-Ro/SSA** and **anti-La/SSB**.- While patients can have arthralgias, the presence of **malar rash**, high **anti-dsDNA**, and severe **nephritis** makes Sjögren's syndrome a less likely primary diagnosis.*Dermatomyositis*- The central features of dermatomyositis are **proximal muscle weakness**, elevated muscle enzymes, and diagnostic skin signs such as the **Heliotrope rash** and **Gottron's papules**.- Severe renal involvement (glomerulonephritis) and high titers of **anti-dsDNA** are not typical findings associated with this primary myopathy, and a malar rash is distinct from typical dermatomyositis rashes.
Explanation: ***Iron deficiency anemia*** - The triad of **microcytic anemia** (MCV 65 fL), extremely low **ferritin** (8 µg/L, indicating absolute iron deficiency), and clinical findings like **fatigue** and **pallor** is pathognomonic for absolute iron deficiency. - **Koilonychia** (spoon-shaped nails) is a classic, though uncommon, physical sign highly specific to severe or chronic iron deficiency anemia. *Vitamin B12 deficiency* - Vitamin B12 deficiency causes **macrocytic anemia** (high MCV), not the microcytic anemia (MCV 65 fL) observed in this patient. - This deficiency is often associated with **neurological symptoms** (e.g., paresthesias) and typically results in normal or elevated ferritin levels. *Thalassemia* - Thalassemia causes **microcytic anemia** but is characterized by a normal or high **ferritin** level (as iron stores are adequate but utilization is impaired). - Diagnosis relies on the demonstration of abnormal hemoglobin chains via **hemoglobin electrophoresis**, not depleted iron stores. *Chronic disease* - Anemia of chronic disease (ACD) typically presents as **normocytic** or mildly microcytic anemia, but the hallmark is **elevated ferritin** (reflecting sequestered iron) and low transferrin saturation. - The severely low **ferritin** (8 µg/L) strongly contradicts the pathophysiology of ACD, where iron stores are adequate but inaccessible. *Folate deficiency* - Similar to B12 deficiency, folate deficiency causes **macrocytic anemia** (high MCV), which does not match the patient's presentation of MCV 65 fL. - This condition is often associated with poor diet or malabsorption and is primarily distinguished by significantly reduced serum folate levels.
Explanation: ***Serum protein electrophoresis***- This test is crucial for detecting and quantifying the **monoclonal protein (M-spike)**, which is the defining laboratory feature of **Multiple Myeloma**.- The clinical presentation—severe bone pain, **multiple lytic lesions**, hypercalcemia, and high ESR—is highly suggestive of a plasma cell malignancy, making SPEP the most helpful initial diagnostic investigation.*Bone marrow biopsy*- While essential for confirming the diagnosis by quantifying **clonal plasma cells**, it is typically performed after the presence of a **monoclonal gammopathy** is established via SPEP/UPEP.- This is an **invasive procedure** and is confirmatory, whereas SPEP is the initial test to identify the hallmark biochemical abnormality.*Bone scan*- Standard **technetium bone scans** are often **negative or misleading** in **Multiple Myeloma** because the lytic lesions lack the osteoblastic phase (new bone formation) needed for tracer uptake.- Plain X-rays, whole-body low-dose CT, or PET scans are superior imaging modalities for assessing the bone destruction (**lytic lesions**) associated with MM.*Parathyroid hormone*- Measuring **PTH** is the standard test to evaluate primary hyperparathyroidism, which is a key differential cause of hypercalcemia.- However, PTH would typically be suppressed in malignancy-associated hypercalcemia, and this test does not explain the concurrent findings of widespread **lytic lesions** and a **raised ESR**.*Vitamin D levels*- While important for general bone health, **Vitamin D levels** are not the primary investigative tool for aggressively destructive bone disease coupled with systemic symptoms like high ESR.- Assessing Vitamin D is more relevant for conditions like osteomalacia or nutritional deficiencies, not a suspected systemic bone malignancy like MM.
Get full access to all questions, explanations, and performance tracking.
Start For Free